Acro Biomedical Statistics

Total Valuation

Acro Biomedical has a market cap or net worth of 1.56 million. The enterprise value is 1.88 million.

Market Cap	1.56M
Enterprise Value	1.88M

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Acro Biomedical has 60.04 million shares outstanding.

Current Share Class	60.04M
Shares Outstanding	60.04M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	49.97%
Owned by Institutions (%)	n/a
Float	30.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-3.65
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.98
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio	0.01
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.19

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-883.72%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	48.07%
Weighted Average Cost of Capital (WACC)	-6.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3,614.29% in the last 52 weeks. The beta is -2.37, so Acro Biomedical's price volatility has been lower than the market average.

Beta (5Y)	-2.37
52-Week Price Change	+3,614.29%
50-Day Moving Average	2.53
200-Day Moving Average	3.39
Relative Strength Index (RSI)	32.27
Average Volume (20 Days)	1,934

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-205,361
Pretax Income	-134,619
Net Income	-134,619
EBITDA	n/a
EBIT	-205,361
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 3,873 in cash and 375,108 in debt, with a net cash position of -371,235 or -0.01 per share.

Cash & Cash Equivalents	3,873
Total Debt	375,108
Net Cash	-371,235
Net Cash Per Share	-0.01
Equity (Book Value)	-427,235
Book Value Per Share	-0.01
Working Capital	-427,235

Full Balance Sheet

Cash Flow

Operating Cash Flow	-223,592
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	199,924
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Acro Biomedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 22, 2017. It was a forward split with a ratio of 3.

Last Split Date	May 22, 2017
Split Type	Forward
Split Ratio	3

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a